Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,425 | -75,367 | -58,983 | -66,052 | -53,163 |
| Depreciation Amortization | 117 | 114 | 44 | 205 | 262 |
| Accounts receivable | -1,491 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,666 | 1,394 | 3,083 | 1,295 | -199 |
| Other Working Capital | 4,859 | -3,018 | 4,753 | -1,684 | -7,079 |
| Other Operating Activity | 5,444 | 8,083 | 8,129 | 9,562 | 5,926 |
| Operating Cash Flow | $-51,829 | $-68,794 | $-42,973 | $-56,675 | $-54,253 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 33,100 | N/A | 30,000 | 10,000 | 10,000 |
| Debt Repayment | -36,143 | -4 | -10,232 | -12,319 | -3,693 |
| Common Stock Issued | 48,028 | 60,334 | 30,024 | 62,513 | 49,895 |
| Other Financing Activity | 0 | 0 | -824 | -600 | -8 |
| Financing Cash Flow | $44,985 | $60,329 | $48,969 | $59,594 | $56,195 |
| Beginning Cash Position | 14,928 | 23,392 | 17,397 | 14,477 | 12,536 |
| End Cash Position | 8,083 | 14,928 | 23,392 | 17,397 | 14,477 |
| Net Cash Flow | $-6,845 | $-8,464 | $5,995 | $2,920 | $1,941 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,829 | -68,794 | -42,973 | -56,675 | -54,253 |
| Free Cash Flow | -51,829 | -68,794 | -42,973 | -56,675 | -54,253 |